NCT01032291 2013-05-21A Study to Assess the Efficacy and Safety of Lenalidomide in Combination With Cetuximab in Pre-treated Patients With KRAS Mutant Colorectal CancerCelgenePhase 2 Terminated51 enrolled 12 charts